The Serum Institute of India’s £50 Million Investment in Oxford Biomedica

Covington & Burling advised Oxford Biomedica on the deal.The Serum Institute of India, the world’s largest vaccine maker, has agreed, via its subsidiary Serum Life Sciences…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Martina Bellini

Author: Martina Bellini

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here